1. Home
  2. AVBP vs EZPW Comparison

AVBP vs EZPW Comparison

Compare AVBP & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • EZPW
  • Stock Information
  • Founded
  • AVBP 2021
  • EZPW 1989
  • Country
  • AVBP United States
  • EZPW United States
  • Employees
  • AVBP N/A
  • EZPW N/A
  • Industry
  • AVBP
  • EZPW Other Specialty Stores
  • Sector
  • AVBP
  • EZPW Consumer Discretionary
  • Exchange
  • AVBP NYSE
  • EZPW Nasdaq
  • Market Cap
  • AVBP 879.2M
  • EZPW 736.7M
  • IPO Year
  • AVBP 2024
  • EZPW 1991
  • Fundamental
  • Price
  • AVBP $21.75
  • EZPW $13.14
  • Analyst Decision
  • AVBP Strong Buy
  • EZPW Buy
  • Analyst Count
  • AVBP 5
  • EZPW 2
  • Target Price
  • AVBP $39.40
  • EZPW $17.75
  • AVG Volume (30 Days)
  • AVBP 172.1K
  • EZPW 541.4K
  • Earning Date
  • AVBP 03-03-2025
  • EZPW 04-30-2025
  • Dividend Yield
  • AVBP N/A
  • EZPW N/A
  • EPS Growth
  • AVBP N/A
  • EZPW 77.06
  • EPS
  • AVBP N/A
  • EZPW 1.14
  • Revenue
  • AVBP N/A
  • EZPW $1,181,781,000.00
  • Revenue This Year
  • AVBP N/A
  • EZPW $9.42
  • Revenue Next Year
  • AVBP N/A
  • EZPW $7.08
  • P/E Ratio
  • AVBP N/A
  • EZPW $11.52
  • Revenue Growth
  • AVBP N/A
  • EZPW 8.95
  • 52 Week Low
  • AVBP $14.35
  • EZPW $9.65
  • 52 Week High
  • AVBP $36.37
  • EZPW $14.50
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 32.12
  • EZPW 47.11
  • Support Level
  • AVBP $21.34
  • EZPW $13.09
  • Resistance Level
  • AVBP $22.75
  • EZPW $13.55
  • Average True Range (ATR)
  • AVBP 1.40
  • EZPW 0.34
  • MACD
  • AVBP -0.14
  • EZPW -0.09
  • Stochastic Oscillator
  • AVBP 8.41
  • EZPW 6.58

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Share on Social Networks: